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Transducer of regulated CREB activity 2 (TORC2) is a coactivator of CREB and an important regulator of
energy balance in mammals through control of gluconeogenesis in the liver. In this issue of Cell Metabolism,
Wang and coworkers (2008) report an intriguing role for Drosophila TORC in the neuronal regulation of
metabolism.Levels of circulating glucose are deter-
mined by the balance between glucose
uptake and utilization and glucose pro-
duction. This balance is maintained by
hormones that regulate intracellular sig-
naling pathways. For most of us well-fed
animals, circulating glucose levels are
periodically elevated, leading to insulin
production, which in turn activates pro-
grams needed for glucose uptake and
energy storage in the form of glycogen
and triglycerides. A constant supply of
ready energy has not always been the
norm, and mechanisms have evolved to
ensure that levels of circulating glucose
are sufficient under conditions of nutrient
deprivation. The pancreatic hormone
glucagon activates the gluconeogenic
program in the liver in response to low
glucose levels. A key regulator of the
gluconeogenic program is the cAMP-
responsive transcription factor CREB
(Herzig et al., 2001). One important medi-
ator in the CREB-regulated gluconeo-
genic transcriptional program is the CREB
coactivator transducer of regulated CREB
activity 2 (TORC2; Conkright et al., 2003).
In this issue ofCell Metabolism, Wang and
coworkers (2008) examine the function of
Drosophila TORC, the single Drosophila
ortholog of the mammalian TORC family
(Iourgenko et al., 2003). Wang et al.
(2008) find that TORC regulation is the
same in flies and mammals, but the bio-
logical context in which TORC works
may differ.
TORC2 is a nodal point in the regulation
of CREB-mediated transcription, as it is
regulated by multiple signaling mecha-
nisms responsive to levels of glucagon,
insulin, and intracellular energy status.
TORC2 is a transcriptional coactivator,
and the key to its regulation lies in the con-
trol of its subcellular location: in or out of
the nucleus. When phosphorylated on
Ser171, mammalian TORC2 is bound by
14-3-3, which keeps it in the cytoplasm,
while dephosphorylation of Ser171 allows
TORC2 to enter the nucleus and coacti-
vate transcription of CREB target genes
(Figure 1; Screaton et al., 2004).
Ser171 of TORC2 is phosphorylated by
the members of the salt-inducible kinase
(SIK) family (Figure 1). SIK2 activity is con-
trolled through glucagon- and insulin-reg-
ulated phosphorylation events. SIK2 is
inhibited by cAMP-responsive protein
kinase A (PKA), which is activated by
glucagon in conditions of low circulating
glucose (Screaton et al., 2004). Con-
versely, SIK2 is activated by insulin
through AKT-mediated phosphorylation
(Dentin et al., 2007). Ser171 can also be
phosphorylated by another SIK family
member, SIK1, which is itself a CREB tar-
get gene upregulated by glucagon (Koo
et al., 2005). Thus, SIK1 acts as a negative
feedback regulator of TORC2 activity and,
consequently, CREB-regulated gene ex-
pression. Under conditions of cellular
energy stress, the gluconeogenic tran-
scriptional program is inhibited. This is
mediated through activation of AMP-acti-
vated protein kinase (AMPK). AMPK can
also phosphorylate Ser171 in TORC2
and inhibit gluconeogenic transcription
by preventing TORC2 nuclear entry (Koo
et al., 2005). Thus, there appear to be
multiple mechanisms by which TORC2
activity can be limited through phosphor-
ylation. Reciprocally, TORC2 activity can
be restored by dephosphorylation. Calci-
neurin/PP2B dephosphorylates Ser171
in a calcium-dependent manner and
thereby renders TORC2 able to enter the
nucleus (Figure 1).
Flies lacking TORC are viable and fer-
tile, but they display striking metabolic
problems. TORC mutants are strongly
sensitive to starvation and oxidative
stress, and they have severely reduced
levels of stored glycogen and lipids. In
Figure 1. Regulation of TORC Activity by
Phosphorylation
Nuclear localization of TORC2 is regulated by
phosphorylation of Ser171, which determines
TORC2 binding to the cytoplasmic scaffold protein
14-3-3. Ser171 is phosphorylated by SIK2, which is
regulated by glucagon and insulin through PKA
and AKT, respectively. Under nutritional stress,
TORC2 is inhibited by AMPK-mediated phosphor-
ylation of Ser171. SIK1 is a CREB target gene that
acts as a negative feedback regulator of CREB-
mediated transcription by phosphorylating
TORC2. Ser171 is dephosphorylated by the
calcium-dependent phosphatase calcineurin/
PP2B (Cn).
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Previewsearlier mammalian studies, themain focus
on TORC2was on its role in the liver as the
major site of gluconeogenesis (Canettieri
et al., 2005; Koo et al., 2005; Dentin
et al., 2007). In this context, it was per-
haps surprising that the metabolic pheno-
types observed in Drosophila were not
due to TORC function in the fat body,
the functional counterpart of liver and ad-
ipose tissue in the fly. In contrast, TORC is
highly expressed in the fly brain, and the
nutritional stress sensitivity observed in
the mutants can be fully rescued by neu-
ronal expression of TORC. A plausible
mechanism for the neuronal function of
TORC in controlling metabolism would
be through affecting the production of in-
sulin-like peptides. However, Wang et al.
(2008) show that insulin production re-
mains unchanged in TORC mutant ani-
mals and that depletion of the insulin-pro-
ducing cells does not change the
starvation sensitivity of the TORC mutant
flies. Thus, the mechanism by which
neuronal TORC controls metabolic stress
resistance remains to be elucidated. In-
terestingly, two recent studies have re-
vealed that TORC1, another member of
the mammalian TORC family, is required
for late-phase long-term potentiation of
hippocampal neurons (Zhou et al., 2006;
Kovacs et al., 2007). Similar to TORC2,
the neuronal TORC1 coactivates CREB
target genes, and its nuclear entry is reg-
ulated by cAMP and calcium. Thus, the
metabolic and neuronal functions of the
distinct mammalian TORC family mem-
bers appear to be mediated by the single
TORC ortholog in Drosophila.
At the molecular level, regulation of
TORC is highly conserved. Drosophila
TORC displays phosphorylation-regu-
lated subcellular localization, determined
by 14-3-3 binding. Inhibition of the Dro-358 Cell Metabolism 7, May 2008 ª2008 ElssophilaSIK2ortholog, either by achemical
inhibitor or by activation of adenylyl
cyclase, leads to dephosphorylation, dis-
sociation of 14-3-3, and subsequent
nuclear localization of TORC. Further sup-
porting the role of SIK2 in suppressing
TORC, the authors show that neuronal
knockdown of SIK2 enhances the stress
resistance of the flies. Also similar to
mammalian systems is the observation
that insulin signaling suppresses TORC
activity in Drosophila. For example, phos-
phorylation of TORC upon refeeding was
shown to be insulin dependent. A second
line of evidence was provided by experi-
ments in which overexpression of TORC
caused a ‘‘rough eye’’ phenotype. This
TORC gain-of-function phenotype was
strongly enhanced by limiting insulin sig-
naling by RNAi-mediated knockdown of
AKT (see Figure 1).
In sum, the study by Wang and co-
workers (2008) shows a significant degree
of conservation in the molecular mecha-
nisms by which phosphorylation is used
to regulate TORC activity. In both flies
and mammals, this mechanism is used
to control energy balance. However, there
are intriguing differences. In mammals,
a major target of TORC2 action is in the
liver to control gluconeogenesis. In flies,
the major site of TORC action is in the
brain, and the specific process under
control remains to be defined. An analo-
gous difference in organization is also
seen in the insulin-producing cells. In
mammals, the site of insulin production
is the islet b cells in the pancreas, whereas
in flies, it is neuroendocrine cells in the
brain. Despite these differences in tissue
organization, the neuroendocrine cells
controllingmetabolism likely share a com-
mon evolutionary origin (Wang et al.,
2007). Future studies will undoubtedlyevier Inc.be aimed at understanding the specific
neuronal mechanisms in TORC function.
Perhaps a deeper understanding of the
interconnections between the different
metabolic control systems acting in the
brain of the fly will provide new insights
into the role of the nervous system in met-
abolic control in mammals.
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